http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2596991-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1b3582ed55f0fca790c9f7cf6e816c0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7015
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 1987-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76e64f2e22ec628383bf2ec9bb80c0df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d5113b5348346ed4421fbaf7dad2b3
publicationDate 1987-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2596991-A1
titleOfInvention LIQUID MEDICINE FOR THE TREATMENT OF PSORIASIS, BASED ON FILM-FORMING POLYMERS
abstract THE INVENTION CONCERNS PHARMACEUTICAL PRODUCTS FOR THE LOCAL AND LOW IRRITANT TREATMENT OF PSORIASIS, CONTAINING SUBSTANCES WITH ANTI-PSORIASIC ACTIVITY IN ITSELF, THE PHARMACEUTICAL PRODUCT BEING A LIQUID PREPARATION OF FILMOGENOUS POLYMERS AND ANTI-PSORIASIC ACTIVITY SUBSTANCES WITH ANTI-ANTI-PSORIASIC MAY COVER IN SITU AND TREAT SKIN AREAS AFFECTED BY PSORIASIS WITH THE MEDICINAL SHEET OR FILM SHAPED "IN STATU NASCENDI" FROM THIS PREPARATION. AS ANTI-PSORIASIC ACTIVE SUBSTANCES, DITHRANOL AND OR GLUCOCORTICOIDS ARE PREFERREDLY USED IN COMBINATION WITH KERATOLYTIC-ACTING UREA.
priorityDate 1986-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4210633-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1504007-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2515045-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1467957-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0006724-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450668640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450108871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414876235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439713
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449827970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10187

Total number of triples: 41.